Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

Value in Health ◽

10.1016/j.jval.2014.08.929 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Disease Activity ◽

The United States ◽

Patterns Of Use ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Treatment patterns of relapsing remitting multiple sclerosis (RRMS) in Europe and the United States

10.26226/morressier.59a3edacd462b8028d8958b7 ◽

2017 ◽

Author(s):

Joanna White

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Treatment Patterns ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States

Value in Health ◽

10.1016/j.jval.2014.08.933 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404-A405

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Oral Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

Value in Health ◽

10.1016/j.jval.2012.03.803 ◽

2012 ◽

Vol 15 (4) ◽

pp. A149

Author(s):

C.A. Carroll ◽

M.A. Oleen-Burkey

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

Value in Health ◽

10.1016/j.jval.2018.04.1400 ◽

2018 ◽

Vol 21 ◽

pp. S206

Author(s):

D Rao ◽

E Heidari ◽

KM Kamal ◽

AA Dashputre

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Cost Effectiveness ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us)

Value in Health ◽

10.1016/j.jval.2015.09.2513 ◽

2015 ◽

Vol 18 (7) ◽

pp. A766

Author(s):

S Narayanan ◽

P O’Meara ◽

J White ◽

J Chan ◽

R Hooper ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Heatlh Care Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis Taking Once Daily Teriflunomide Tablets in the United States

Value in Health ◽

10.1016/j.jval.2015.09.054 ◽

2015 ◽

Vol 18 (7) ◽

pp. A878

Author(s):

N Greene ◽

M Greene

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Download Full-text

Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

Value in Health ◽

10.1016/j.jval.2014.08.934 ◽

2014 ◽

Vol 17 (7) ◽

pp. A405

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Oral Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Treatment Dynamics And Disease Burden Among Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Currently Treated With Disease Modifying Treatments (Dmts) In The United States

Value in Health ◽

10.1016/j.jval.2014.03.382 ◽

2014 ◽

Vol 17 (3) ◽

pp. A65

Author(s):

S. Narayanan ◽

H. Khan ◽

S. Gabriele ◽

J. White

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Disease Burden ◽

The United States ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

Patient Preference and Adherence ◽

10.2147/ppa.s306498 ◽

2021 ◽

Vol Volume 15 ◽

pp. 1515-1527

Author(s):

Jinender Kumar ◽

M Janelle Cambron-Mellott ◽

Tom Tencer ◽

Oliver Will ◽

deMauri S Mackie ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Choice Experiment ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

Value in Health ◽

10.1016/j.jval.2015.09.2500 ◽

2015 ◽

Vol 18 (7) ◽

pp. A763

Author(s):

N Greene ◽

M Greene

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text